Hsf1 was previously shown to be upregulated in CAFs in breast and lung cancers and to drive a stromal tumor-promoting transcriptional program that correlated with worse prognosis (Scherz-Shouval et al., 2014). The gene discussed is HSF1; the disease is lung cancer.